Graves Orbitopathy and Definitive Treatment Choice
A 37-year-old woman, para 5, has had Graves disease for five years. It is controlled on carbimazole, but two attempts at stopping the drug caused biochemical relapse. Examination shows severe bilateral exophthalmos with lid retraction and diplopia. Ultrasound shows a normal sized, homogeneously hypervascular thyroid. Which of the following findings most strongly indicates thyroidectomy rather than radioactive iodine?
- A.The severe bilateral exophthalmosCorrect
- B.The hypervascular homogeneous thyroid
- C.Relapse after stopping antithyroid drugs
- D.Her age of 37 years
Explanation
This patient needs definitive treatment because she has relapsed twice after withdrawal of carbimazole, but the question is which definitive treatment is safe for her. Graves orbitopathy is driven by the same TSH receptor antibodies that stimulate the thyroid, and orbital fibroblasts express that receptor, which is why the eyes and the gland share an immunological fate. Radioiodine causes destruction of thyroid tissue with release of antigen and a transient surge in TSH receptor antibodies, which can trigger new eye disease or worsen existing disease, particularly when it is active and severe as here with lid retraction and diplopia. Radioiodine is therefore relatively or absolutely contraindicated in this setting, and if it is used in milder cases prophylactic glucocorticoids and prompt correction of hypothyroidism are required. Total thyroidectomy removes the antigenic source, cures the hyperthyroidism immediately, and does not aggravate and may improve the orbital disease over time. Relapse after drug withdrawal explains why definitive therapy is required at all, but it is an indication for radioiodine just as much as for surgery, so it cannot decide between them. Diffuse hypervascularity is simply the characteristic sonographic appearance of an actively stimulated Graves gland. Her age of 37 years makes her a suitable candidate for either modality and is not a discriminating factor.
Why each option
- A.
- Correct. Severe active orbitopathy contraindicates radioiodine because of the risk of an immunological flare, leaving thyroidectomy as the definitive option.
- B.
- A homogeneously hypervascular gland is the expected ultrasound picture in Graves disease and does not affect the treatment decision.
- C.
- Relapse after drug withdrawal signals the need for definitive therapy but supports radioiodine and surgery equally.
- D.
- At 37 years she is eligible for either treatment; age influences the choice mainly in children and in women planning imminent pregnancy.
Reference: American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism, Thyroid, 2016; European Group on Graves Orbitopathy guidelines, 2021
This is one of 3,009 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank